Reckitt-Benckiser-072814.jpg Consumer goods giant Reckitt Benckiser Group Plc Monday reported higher first-half profit, as like-for-like revenue grew on consumer health performance. The company also said it will spin off its pharmaceutical unit Reckitt Benckiser Pharmaceuticals, or RBP.

TNT-Express-072814.jpg TNT Express NV reported narrower net loss in its second quarter on lower charges amid restructuring initiatives and margin strength with profit improvements in Brazil, AMEA and certain parts of Europe. Meanwhile, revenues were lower than last year. The company said its outlook strategy is on track, and confirmed its fiscal 2014 forecast. The stock is currently trading around 6 percent lower.

Ryanair-072814.jpg Irish low-cost airline Ryanair Holdings PLC (RYA.L, RYAAY) Monday said first-quarter profit increased significantly from the previous year, supported by a very strong Easter. The company also boosted its full-year profit forecast, adding that it is dependent on the final outturn for second-half yields.

Protein-Bars-072814.jpg Extend Nutrition, a manufacturer of gluten-free snacks, which recently hit a new sales milestone of 25 million protein bars, has announced a giveaway to celebrate the achievement.

Asian-Markets1_28Jul14.jpg European stocks look set to open slightly higher on Monday following Friday's sell-off. That said, renewed geopolitical worries continue to weigh on investors' minds, driving demand for safe-haven assets. Israel and Hamas launched new attacks Sunday in the raging Gaza war after offering a humanitarian...

danone-072814.jpg French consumer products and dairy giant Danone SA is in talks to sell its medical nutrition unit to U.S. pharmaceutical and medication delivery company Hospira, Inc. in a deal that could value the unit at nearly $5 billion, according to media reports on Sunday. A deal, if successful, would be the latest among a series of so-called tax inversion deals meant to avoid significantly higher U.S taxes.

wallstreet4-103112_25Jul14.jpg Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high.

Oil2-041912_25Jul14.jpg U.S. crude oil ended a tad higher on Friday, after some upbeat data with some better than expected orders for durable goods from the U.S., with investors continued focus on the developments in the Middle East and Ukraine. Investors continued to monitor the developments in Ukraine and the Middle East,...

Obama2-072514.jpg President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border.

Goldbar-041213_25Jul14.jpg Gold futures snapped a three-day loss to end higher on Friday, tracking some largely declining global equity markets with investors seeking the precious metal's safe haven appeal, even as the situation in Ukraine continued to escalate. Although weak global equity markets and short-covering after...

Obama-072514.jpg Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.

Wallstreet-013013_25Jul14.jpg After coming under pressure in early trading, stocks have seen some further downside over the course of the trading day on Friday. With the losses on the day, the S&P 500 is pulling back well off the record closing high that it set in the previous session.

Wallstreet4-111212_25Jul14.jpg With disappointing earnings news generating some selling pressure, stocks have moved mostly lower in early trading on Friday. The major averages have slid firmly into negative territory after ending the previous session nearly flat.

DurableGoodsOrders-072514.jpg After reporting an unexpected drop in new orders for U.S. manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than expected in the month of June.

AbbVie-072514.jpg Research-based biopharmaceutical company AbbVie Inc. on Friday reported a 3 percent increase in profit for the second quarter from last year on higher revenues, reflecting strong sales of the company's blockbuster rheumatoid arthritis drug Humira. Both revenue and adjusted earnings per share for the quarter beat analysts' estimates. Tthe company affirmed its earnings outlook for fiscal 2014.